Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions, Liquids, Solids, Transdermal Products), Route (Dermal, Rectal, Vaginal), Patient Care Setting (Homecare, Hospital, Burn Center) COVID-19 Impact - Global Forecast to 2025

Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions, Liquids, Solids, Transdermal Products), Route (Dermal, Rectal, Vaginal), Patient Care Setting (Homecare, Hospital, Burn Center) COVID-19 Impact - Global Forecast to 2025

The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4% during the forecast period. The growth of this market is majorly driven by the high prevalence of skin and soft tissue infections, the increasing prevalence of eye diseases, and burns. However, the presence of alternative drug delivery modes such as oral and injectable routes is expected to restrain the growth of this market during the forecast period.

Based on product, the semi-solid formulations segment holds the largest market share during the forecast period.
Based on product, the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. The semi-solid formulations segment accounted for the larger market share in 2019. The easy application of semi-solid formulations, and their ability to deliver a wide variety of drug molecules is resulting in a stable demand for this segment among end users.

Based on route of administration, the dermal drug delivery segment is expected to register the highest CAGR during the forecast period.
Based on route of administration, the topical drug delivery market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal, vaginal drug delivery, and nasal drug delivery. The dermal drug delivery segment is expected to witness the highest growth during the forecast period. This is mainly due to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance. Besides, dermal products have fewer regulatory requirements than ophthalmic products, where sterility testing is mandatory.

The home care settings segment is expected to account for the largest share of the topical drug delivery market in 2019
The home care settings segment accounted for the largest share of the market in 2019. This is attributed to the factors such as the convenience and affordability of topical drugs for home administration. Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. In this regard, technological advancements have helped patients undergo therapies effectively and safely at home.

Asia Pacific is expected to grow at the highest CAGR in the topical drug delivery market during the forecast period
The topical drug delivery market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is due to high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, all of which are driving adoption of topical drug delivery in the Asia Pacific.

Break of primary participants was as mentioned below:
By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
By Designation – C-level–43%, Director-level–32%, Others–25%
By Region – North America–38%, Europe–29%, Asia Pacific–23%, RoW- 10%
Key players in the topical drug delivery market

The key players operating in the topical drug delivery market include Johnson & Johnson (US), Nestlé SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), Mylan (US), Encore Dermatology, Inc. (US), LEO Pharma (Denmark), Almirall, S.A (Spain), Aclaris Therapeutics, Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Teligent Pharma (US), Perrigo Pharma (US), Allergan (Ireland), Biofrontera, Inc. (US), Crown Laboratories Inc. (US), Akorn Inc. (US), Ingenus Pharmaceuticals (US), and Sun Pharmaceuticals (India).

Research Coverage:
The report analyzes the topical drug delivery market and aims at estimating the market size and future growth potential of this market based on various segments such as product, route of administration, facility of use, and region. The report also includes a product portfolio matrix of various topical drug delivery products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by the top players in the global topical drug delivery market. The report analyzes this market by product, route of administration, and facility of use
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global topical drug delivery market
Market Development: Comprehensive information on the lucrative emerging markets by product, route of administration, and facility of use
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global topical drug delivery market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global topical drug delivery market.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZING & VALIDATION APPROACH
    • MARKET DATA VALIDATION AND TRIANGULATION
    • MARKET SHARE ANALYSIS
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • TOPICAL DRUG DELIVERY MARKET OVERVIEW
    • ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT AND COUNTRY, 2019
    • TOPICAL DRUG DELIVERY MARKET, BY REGION (2018-2025)
    • TOPICAL DRUG DELIVERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • COVID-19 IMPACT ON THE TOPICAL DRUG DELIVERY MARKET
  • TOPICAL DRUG DELIVERY MARKET, BY PRODUCT
    • INTRODUCTION
    • COVID-19 IMPACT, BY PRODUCT
      • Table TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
    • SEMI-SOLID FORMULATIONS
      • Table TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY COUNTRY, 2020–2025 (USD MILLION)
      • CREAMS
        • Table TOPICAL DRUG DELIVERY MARKET FOR CREAMS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR CREAMS, BY COUNTRY, 2020–2025 (USD MILLION)
      • OINTMENTS
        • Table TOPICAL DRUG DELIVERY MARKET FOR OINTMENTS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR OINTMENTS, BY COUNTRY, 2020–2025 (USD MILLION)
      • LOTIONS
        • Table TOPICAL DRUG DELIVERY MARKET FOR LOTIONS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR LOTIONS, BY COUNTRY, 2020–2025 (USD MILLION)
      • GELS
        • Table TOPICAL DRUG DELIVERY MARKET FOR GELS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR GELS, BY COUNTRY, 2020–2025 (USD MILLION)
      • PASTES
        • Table TOPICAL DRUG DELIVERY MARKET FOR PASTES, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR PASTES, BY COUNTRY, 2020–2025 (USD MILLION)
    • LIQUID FORMULATIONS
      • Table TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2020–2025 (USD MILLION)
      • SUSPENSIONS
        • Table TOPICAL DRUG DELIVERY MARKET FOR SUSPENSIONS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR SUSPENSIONS, BY COUNTRY, 2020–2025 (USD MILLION)
      • SOLUTIONS
        • Table TOPICAL DRUG DELIVERY MARKET FOR SOLUTIONS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR SOLUTIONS, BY COUNTRY, 2020–2025 (USD MILLION)
    • SOLID FORMULATIONS
      • Table TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY COUNTRY, 2020–2025 (USD MILLION)
      • POWDERS
        • Table TOPICAL DRUG DELIVERY MARKET FOR POWDERS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR POWDERS, BY COUNTRY, 2020–2025 (USD MILLION)
      • SUPPOSITORIES
        • Table TOPICAL DRUG DELIVERY MARKET FOR SUPPOSITORIES, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR SUPPOSITORIES, BY COUNTRY, 2020–2025 (USD MILLION)
    • TRANSDERMAL PRODUCTS
      • Table COMPARISON BETWEEN TRANSDERMAL PATCHES AND TRANSDERMAL SEMI-SOLID FORMULATIONS
      • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY COUNTRY, 2020–2025 (USD MILLION)
      • TRANSDERMAL PATCHES
        • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PATCHES, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PATCHES, BY COUNTRY, 2020–2025 (USD MILLION)
      • TRANSDERMAL SEMI-SOLIDS
        • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL SEMI-SOLIDS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL SEMI-SOLIDS, BY COUNTRY, 2020–2025 (USD MILLION)
  • TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION
    • INTRODUCTION
    • COVID-19 IMPACT, BY ROUTE OF ADMINISTRATION
      • Table TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
    • DERMAL DRUG DELIVERY
      • DERMAL DRUG DELIVERY IS THE LARGEST SEGMENT IN THIS MARKET
        • Table DERMAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table DERMAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    • OPHTHALMIC DRUG DELIVERY
      • INCREASING USE OF MOBILE DEVICES IS LIKELY TO IMPACT VISION, WHICH IS A KEY FACTOR SUPPORTING MARKET GROWTH
        • Table OPHTHALMIC DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table OPHTHALMIC DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    • RECTAL DRUG DELIVERY
      • POOR ABSORPTION OF DRUGS THROUGH THE RECTAL ROUTE—A KEY DISADVANTAGE ASSOCIATED WITH THIS MARKET SEGMENT
        • Table RECTAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table RECTAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    • VAGINAL DRUG DELIVERY
      • SCOPE OF SELF-ADMINISTRATION AND EASE OF MANUFACTURING TO BOOST THE GROWTH OF THE VAGINAL DRUG DELIVERY MARKET SEGMENT
        • Table VAGINAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table VAGINAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
    • NASAL DRUG DELIVERY
      • HIGH EFFICACY OF NASALLY ADMINISTERED DRUGS AND GROWING PREFERENCE FOR SELF-ADMINISTRATION TO DRIVE MARKET GROWTH
        • Table NASAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table NASAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
  • TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE
    • INTRODUCTION
      • Table TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
    • HOME CARE SETTINGS
      • HOME CARE SETTINGS ACCOUNTED FOR THE LARGEST SHARE IN 2019
        • Table TOPICAL DRUG DELIVERY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2025 (USD MILLION)
    • HOSPITALS AND CLINICS
      • RISING INCIDENCE OF SURGICAL-SITE INFECTIONS TO DRIVE MARKET GROWTH
        • Table TOPICAL DRUG DELIVERY MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2025 (USD MILLION)
    • BURN CENTERS
      • HIGH INCIDENCE OF BURN INJURIES ACROSS THE GLOBE TO SUPPORT THE MARKET GROWTH
        • Table TOPICAL DRUG DELIVERY MARKET FOR BURN CENTERS, BY COUNTRY, 2017–2019 (USD MILLION)
        • Table TOPICAL DRUG DELIVERY MARKET FOR BURN CENTERS, BY COUNTRY, 2020–2025 (USD MILLION)
    • OTHER FACILITIES
      • Table TOPICAL DRUG DELIVERY MARKET FOR OTHER FACILITIES, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET FOR OTHER FACILITIES, BY COUNTRY, 2020–2025 (USD MILLION)
  • TOPICAL DRUG DELIVERY MARKET, BY REGION
    • INTRODUCTION
    • COVID-19 IMPACT, BY REGION
      • Table TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2019 (USD MILLION)
      • Table TOPICAL DRUG DELIVERY MARKET, BY REGION, 2020–2025 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
      • Table NORTH AMERICA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • US
        • Table PRODUCT APPROVALS & LAUNCHES IN THE US MARKET (2017–2019)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table US: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • CANADA
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table CANADA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
    • EUROPE
      • Table RECENT DEVELOPMENTS IN THE EUROPEAN TOPICAL DRUG DELIVERY MARKET, 2015–2018
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
      • Table EUROPE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • GERMANY
        • Table DEVELOPMENTS IN THE FIELD OF TOPICAL DRUG DELIVERY IN GERMANY, 2017–2019
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table GERMANY: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • UK
        • Table DEVELOPMENTS IN THE TOPICAL DRUG DELIVERY MARKET IN THE UK, 2016–2019
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table UK: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • FRANCE
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table FRANCE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table ROE: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
    • ASIA PACIFIC
      • Table DEVELOPMENTS IN THE TOPICAL DRUG DELIVERY MARKET IN THE ASIA PACIFIC, 2016–2019
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
      • Table ASIA PACIFIC: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • JAPAN
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table JAPAN: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • CHINA
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table CHINA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • INDIA
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table INDIA: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
        • Table ROAPAC: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR SEMI-SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR LIQUID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR SOLID FORMULATIONS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET FOR TRANSDERMAL PRODUCTS, BY TYPE, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2020–2025 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2017–2019 (USD MILLION)
      • Table ROW: TOPICAL DRUG DELIVERY MARKET, BY FACILITY OF USE, 2020–2025 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES
      • EXPANSIONS
        • Table EXPANSIONS
      • AGREEMENTS AND COLLABORATIONS
        • Table AGREEMENTS AND COLLABORATIONS
      • ACQUISITIONS
        • Table ACQUISITIONS
    • COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
      • STAR PLAYERS
      • EMERGING LEADERS
      • PERVASIVES
      • EMERGING COMPANIES
  • COMPANY PROFILES
    • BAUSCH HEALTH COMPANIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • HISAMITSU PHARMACEUTICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • NESTLÉ SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GLENMARK PHARMACEUTICALS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • CIPLA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • CRESCITA THERAPEUTICS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MYLAN N.V.
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
    • GLAXOSMITHKLINE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JANSSEN GLOBAL SERVICES (A SUBSIDIARY OF JOHNSON & JOHNSON)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • 3M
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MERCK & CO.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BAYER AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOEHRINGER INGELHEIM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • OTHER MAJOR COMPANIES
      • TEVA PHARMACEUTICALS
      • BRISTOL-MYERS SQUIBB
      • LEAD CHEMICALS CO., INC.
      • LAVIPHARM
      • PURDUE PHARMA L.P.
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook